Share This Page
Suppliers and packagers for generic pharmaceutical drug: estradiol; norethindrone acetate; relugolix
✉ Email this page to a colleague
estradiol; norethindrone acetate; relugolix
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Sumitomo Pharma Am | MYFEMBREE | estradiol; norethindrone acetate; relugolix | TABLET;ORAL | 214846 | NDA | Sumitomo Pharma America, Inc | 72974-415-01 | 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-01) | 2021-05-26 |
| Sumitomo Pharma Am | MYFEMBREE | estradiol; norethindrone acetate; relugolix | TABLET;ORAL | 214846 | NDA | Sumitomo Pharma America, Inc | 72974-415-99 | 7 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-99) | 2021-05-26 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
ppliers for the Pharmaceutical Drugs: Estradiol, Norethindrone Acetate, and Relugolix
Introduction
The pharmaceutical industry continuously evolves, driven by innovation, regulatory standards, and global demand. Central to this ecosystem are the suppliers that manufacture active pharmaceutical ingredients (APIs). For drugs such as estradiol, norethindrone acetate, and relugolix, identifying reliable API suppliers is crucial for pharmaceutical companies aiming to ensure quality, compliance, and cost-effectiveness. This article provides a comprehensive overview of the leading suppliers engaged in the production and supply of these crucial hormones and therapeutic agents, highlighting their capabilities, market presence, and strategic importance.
Overview of the Drugs
Estradiol, norethindrone acetate, and relugolix belong to distinct classes, yet they are often combined in hormone therapy and reproductive health applications. Their supply chains are complex, involving rigorous quality standards, regulatory oversight, and global logistics.
- Estradiol is a primary estrogen used in hormone replacement therapy, contraception, and various estrogen deficiency treatments ([1]).
- Norethindrone acetate is a progestin widely employed in contraceptives and hormone therapy ([2]).
- Relugolix is a newer oral GnRH receptor antagonist approved for treating conditions like uterine fibroids and prostate cancer ([3]).
Key Suppliers for Estradiol
1. Novartis (Sandoz)
Sandoz, a division of Novartis, is a leading producer of generic APIs, including estradiol. They specialize in high-purity, pharmaceutical-grade estradiol used in various formulations. Their global manufacturing footprint ensures a consistent supply chain that meets international regulatory standards.
2. Teva Pharmaceutical Industries Ltd.
Teva is one of the world's largest generic drug manufacturers, with extensive experience in producing estradiol APIs. Their manufacturing facilities adhere to cGMP standards, and they supply APIs to multiple markets worldwide.
3. Dr. Reddy’s Laboratories
Dr. Reddy’s has a significant API production capacity for estradiol, serving both generic and branded drug markets. Their strategic investments in quality control have positioned them as a reliable supplier.
4. Zhejiang Hisun Pharmaceutical Co., Ltd.
A Chinese pharmaceutical firm, Hisun, offers competitive pricing and manufacturing of estradiol. Their implementation of GMP standards aligns them with international supply chain requirements ([4]).
5. Polpharma
Based in Poland, Polpharma supplies high-quality estradiol APIs across Europe and beyond, maintaining COS standards and GMP compliance.
Suppliers for Norethindrone Acetate
1. Synthon Pharmaceuticals
Synthon specializes in hormonal APIs, including norethindrone acetate. Their focus on quality and consistency makes them a preferred supplier globally.
2. Hetero Labs Limited
An Indian pharmaceutical giant, Hetero is renowned for manufacturing a wide spectrum of hormonal APIs, including norethindrone acetate specific to the reproductive health market ([5]).
3. Cipla Ltd.
Cipla is a key player offering norethindrone acetate APIs, with a robust supply chain supporting both generics and branded formulations.
4. Jiangsu Hengrui Medicine Co., Ltd.
A Chinese manufacturer, Hengrui supplies hormonal APIs with high GMP standards, expanding their reach into international markets.
5. Mylan/Natco Pharma
Mylan's integration with Natco ensures a steady supply of norethindrone acetate, emphasizing stringent quality controls aligned with global standards.
Suppliers for Relugolix
1. Takeda Pharmaceutical Company
Takeda developed relugolix and is its primary supplier, overseeing both manufacturing and distribution. Their expertise in biologics and small molecule synthesis supports consistent API production ([3]).
2. Hetero Labs
Hetero has entered the relugolix supply chain, producing high-quality APIs aligned with Takeda’s specifications to meet global demand.
3. Zhejiang Hisun Pharmaceutical Co., Ltd.
Hisun has been expanding into newer hormonal agents, including relugolix, leveraging their GMP-compliant manufacturing footprint for quality production.
4. Dr. Reddy’s Laboratories
Dr. Reddy's is exploring API manufacturing in alignment with the growing demand for relugolix, especially as the drug gains approval in multiple indications.
5. Emerging Contract Manufacturers
Several contract manufacturing organizations (CMOs) have begun developing relugolix APIs to support Takeda’s global distribution, emphasizing quality scalability and cost efficiency.
Global Supply Chain Considerations
The supply of estradiol, norethindrone acetate, and relugolix spans multiple continents, with notable manufacturing hubs in India, China, Europe, and North America. Regulatory compliance with FDA, EMA, and other agencies is paramount, necessitating vendors maintain cGMP standards. Additionally, geopolitical factors, trade agreements, and raw material sourcing influence supplier stability and pricing.
Quality Assurance and Regulatory Compliance
Suppliers must demonstrate strict adherence to pharmacopeial standards (USP, EP, JP) and ISO certifications. Any disruptions in the supply chain can impact global drug availability, prompting companies to diversify sources and maintain strategic stockpiles.
Pricing and Contracting Strategies
Cost competitiveness often stems from the scale of API manufacturing, raw material availability, and manufacturing efficiency. Strategic partnerships or long-term contracts with key suppliers can optimize margins and mitigate supply risks.
Market Trends and Future Outlook
The rising demand for hormone therapies, personalized medicine, and biosimilars fuels the need for reliable APIs. The entry of new players and technological advancements, such as continuous manufacturing, are expected to streamline supply chains. Moreover, the regulatory landscape tightening standards globally necessitates ongoing supplier audits and quality improvements.
Relugolix's recent approval and novel mechanism of action position it as a high-growth segment, prompting pharmaceutical companies to establish robust, scalable supply arrangements with primary manufacturers such as Takeda.
Key Takeaways
- Leading API suppliers for estradiol include Novartis (Sandoz), Teva, and Dr. Reddy’s, with China-based manufacturers like Zhejiang Hisun providing competitive alternatives.
- Norethindrone acetate suppliers encompass Synthon, Hetero, Cipla, and multinational firms like Mylan/Natco, emphasizing high-quality hormonal API production.
- Relugolix is primarily supplied by Takeda, with support from Hetero and emerging CMOs to meet expanding global demand.
- Regulatory standards and quality assurance are critical in maintaining supply chain integrity amid increasing market complexities.
- Diversification of sources remains vital for mitigating geopolitical and logistical risks, ensuring consistent drug availability.
FAQs
Q1: How do geopolitical factors influence API supply chains for hormones like estradiol?
A: Geopolitical tensions, trade restrictions, and tariffs can disrupt manufacturing and logistics, prompting companies to diversify suppliers across different regions to maintain stability and compliance.
Q2: What quality standards are mandated for pharmaceutical API suppliers?
A: Suppliers must comply with cGMP, adhere to pharmacopeial standards (USP, EP, JP), and maintain ISO certifications to ensure API safety, quality, and efficacy.
Q3: Who are the emerging suppliers of relugolix, and what advantages do they offer?
A: Emerging contract manufacturers are entering the relugolix supply chain, offering scalable production capabilities, cost efficiencies, and strategic partnerships to meet increasing demand.
Q4: How does raw material sourcing impact hormone API manufacturing?
A: Raw material availability and cost affect production capacity and pricing. Reliable sourcing from suppliers with sustainable practices ensures consistent API quality and supply.
Q5: What are the future trends shaping API supply for hormone therapies?
A: Technological innovations like continuous manufacturing, increased regulatory focus on quality, and the rising prevalence of hormone-related conditions will drive diversified, resilient API supply chains.
References
[1] U.S. Pharmacopeia. (2022). Estradiol monograph.
[2] European Pharmacopoeia. (2021). Norethindrone acetate monograph.
[3] Takeda Pharmaceutical. (2022). Relugolix regulatory and manufacturing updates.
[4] Zhejiang Hisun Pharmaceutical Co., Ltd. Corporate website.
[5] Hetero Labs Ltd. Product portfolio and quality standards.
More… ↓
